Fact CheckerSign in

NCT05820074Recruiting

Investigating Neural Biomarkers for Gait in Parkinson's Patients

Source: ClinicalTrials.gov · Last updated 3 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This observational study's main goal is to learn more about the neural mechanisms during movement in Parkinson's disease. Furthermore, it aims to inspire personalised treatment options. Participants will undergo a protocol that involves walking and gait-related motor tasks, such as seated stepping. During the protocol, brain activity will be recorded.

Status (registry)
Recruiting
Study type
Observational
Enrollment
60 (estimated)
First submitted
13 Dec 2022
Start date
13 Apr 2023
Primary completion date
Mar 2025
Lead sponsor
Swiss Federal Institute of Technology
NCT number
NCT05820074

What you commit to

  • Study type: Observational
  • Planned participants: 60
  • From 13 Apr 2023 to the primary completion date, Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Relevant cognitive impairment, with a score on Montréal Cognitive Assessment (MoCA) \< 20
  • History of physical or neurological condition that interferes with study procedures

Other

  • Social and/or personal circumstances interfering with the ability to come to the session

Who the study is looking for

  • All participants
  • must have given informed consent as documented by signature
  • agree to comply with the study procedures
    • Healthy control group
  • no neurological, orthopedic, or rheumatologic disease history
  • no identified sensory impairment.
  • no epilepsy and self-diagnosed acute or chronic psychiatric disorders
    • Parkinson's Patients
  • non-tremor dominant idiopathic PD patients
  • presence of postural instability (UPDRS \>1 for postural instability \[17\]), gait disturbance, and absence of other causes of reduced balance
  • Implanted with Percept™ PC neurostimulator
  • Able to be in the stimulation OFF

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cereneo
Coordinator of this site? Confirm its status
VitznauSwitzerlandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.